文献速递认知障碍与痴呆

肾功能、阿尔茨海默病血液标志物与社区老年人痴呆风险

Kidney Function, Alzheimer Disease Blood Biomarkers, and Dementia Risk in Community-Dwelling Older Adults.
PubMed 文献 · Neurology · 2025-12-03

基于瑞典SNAC-K纵向人群研究,纳入2279名基线无痴呆的社区老年人,中位年龄72岁、女性62%。较低eGFR与除Aβ42/40外多数AD血液标志物升高呈非线性关联,但eGFR<60并未独立增加痴呆风险,而是放大了NfL与痴呆的关联。

要点

  • 低eGFR与多数AD血液标志物升高相关,Aβ42/40除外。
  • eGFR<60未独立增加痴呆风险(HR 0.93,95%CI 0.72-1.21)。
  • 肾功能受损时NfL与痴呆关联更强(HR 3.85 vs 1.84)。

核心结论

  • 肾功能受损与多数AD血液标志物循环水平升高相关,但不独立增加痴呆风险,似加速潜在神经退行性病理的临床表达。

研究设计与样本

  • 瑞典SNAC-K纵向人群研究,基线纳入2279名无痴呆且有空腹血样的社区老年人,中位年龄72岁(IQR 61-81),女性62%。
  • eGFR基于血清肌酐评估,AD血液标志物用Simoa平台检测,痴呆按DSM-IV诊断,随访平均8.3年(SD 4.3)。

主要发现

  • 较低eGFR与除Aβ42/40外所有受检AD血液标志物中位z-score升高呈非线性关联。
  • eGFR=30 mL/min/1.73 m2时估计差异:p-tau181 β 0.22(95%CI 0.09-0.35)、p-tau217 β 0.20(95%CI 0.10-0.31)、t-tau β 0.24(95%CI 0.05-0.42)、NfL β 0.88(95%CI 0.80-0.95)、GFAP β 0.10(95%CI 0.03-0.16)。
  • 随访期间362人发生痴呆;eGFR<60 vs ≥60的痴呆风险HR 0.93(95%CI 0.72-1.21)。
  • 高vs低NfL与痴呆关联在肾功能受损者HR 3.85(95%CI 1.87-7.95),肾功能保留者HR 1.84(95%CI 1.34-2.53)。

临床怎么用

  • 解读AD血液标志物时需结合eGFR,肾功能受损者标志物升高不一定提示痴呆风险独立增加。
  • 肾功能受损人群中NfL与痴呆关联更强,可辅助识别高风险个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Impaired kidney function has been linked to altered concentrations of blood biomarkers of Alzheimer disease (AD), but the underlying mechanisms and its potential role in dementia development remain poorly understood. We explored the associations between estimated glomerular filtration rate (eGFR), blood-based biomarkers of AD, and dementia development. METHODS: Data were extracted from the Swedish National Study on Aging and Care in Kungsholmen, an ongoing longitudinal population-based study. Kidney function was assessed using eGFR based on serum creatinine. AD biomarkers (amyloid beta [Aβ42/40], phosphorylated tau [p-tau181 and p-tau217] and total tau [t-tau] proteins, neurofilament light chain [NfL], and glial fibrillary acidic protein [GFAP]) were measured from peripheral blood samples using the Simoa platform. Dementia was diagnosed according to DSM-IV criteria. Quantile regression models assessed the cross-sectional associations between eGFR and AD biomarkers; Cox regression models were used to examine the association of kidney function and biomarkers with incident dementia. RESULTS: At baseline, 2,279 dementia-free participants with available blood samples were included (median age 72 (interquartile range, 61-81) years; 62% female). Lower eGFR was associated with higher median z-score levels of all examined AD blood biomarkers, except Aβ42/40, following a nonlinear relationship. At eGFR = 30 mL/min/1.73 m2, estimated differences were as follows: p-tau181: β, 0.22 [95% CI 0.09-0.35]; p-tau217: β, 0.20 [95% CI 0.10-0.31]; t-tau: β, 0.24 [95% CI 0.05-0.42]; NfL: β, 0.88 [95% CI 0.80-0.95]; GFAP: β, 0.10 [95% CI 0.03-0.16]. During a mean follow-up period of 8.3 (SD, 4.3) years, 362 participants developed dementia. In multivariable-adjusted models, impaired kidney function (eGFR < 60 mL/min/1.73 m2) was not associated with an increased hazard of dementia compared with preserved kidney function (eGFR ≥ 60 mL/min/1.73 m2) (hazard ratio [HR], 0.93 [95% CI 0.72-1.21]). The relationship between increased (high vs low) NfL and dementia was stronger among individuals with impaired (vs preserved) kidney function (HR, 3.85 [95% CI 1.87-7.95] vs HR, 1.84 [95% CI 1.34-2.53], respectively). DISCUSSION.: Impaired kidney function was associated with elevated circulating level of most AD blood biomarkers. However, the presence of impaired kidney function did not independently increase the risk of dementia but rather seemed to accelerate the clinical expression of underlying neurodegenerative pathology.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Gasparini F, Valletta M, Vetrano DL, et al. Kidney Function, Alzheimer Disease Blood Biomarkers, and Dementia Risk in Community-Dwelling Older Adults. Neurology. 2025. PMID: 41337685. doi:10.1212/WNL.0000000000214446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。